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Clinical Characteristics of Patients with Acute Pulmonary Embolism 
Paul D. Stein, MD, Herbert A. Saltzman, MD, and John G. Weg, MD 
A 
mong 117 patients with pulmonary embolism 
(PE) and no prior cardiac or pulmonary disease 
who participated in the National Heart, Lung, 
and Blood Institute Prospective Investigation of Puhno- 
nary Embolism Diagnosis (PIOPED) study, combina- 
tions of clinical characteristics were identified that were 
present in nearly all in whom the diagnosis of PE was 
made.’ We now assess these as well as additional com- 
binations of characteristics in the entire population of 
patients with acute PE who participated in PIOPED, 
irrespective of the presence of prior cardiopulmonary 
disease. 
The eligible population consisted of patients aged 
218 years in whom acute PE was of diagnostic con- 
cern. Symptoms suggestive of PE were required with- 
in 24 hours of entry into the study.2 The PIOPED 
study consisted of 2 groups. In 1 group, patients who 
consented to participate in the investigation were obli- 
gated to undergo pulmonary angiography if their ven- 
tilation/perfusion scans were abnormal. There were 
251 patients with acute PE in this arm of the PIOPED 
study in whom the diagnosis was made by angiogra- 
phy.2 There was a second group in the PIOPED study 
which was not described in the PIOPED report. This 
group included patients who by random sample were 
not selected for sensitivity and specificity analyses of 
their ventilation/perfusion scans, and who, therefore, 
were not obligated by protocol to undergo angiogra- 
phy if their ventilation/perfusion scans were abnor- 
mal. Also in this group were patients who refused 
mandatory angiography and, therefore, refused to 
participate in the first arm of the study. However, 
many of these patients underwent diagnostic angiog- 
raphy at the request of their attending physicians. 
There were 132 patients in this arm of the study who 
had PE diagnosed by angiography. The present inves- 
tigation reports the clinical characteristics of acute 
PE in the 383 patients with acute PE who were in 
either arm of the PIOPED study. Comparisons were 
made with 843 patients in whom suspected PE was 
excluded, either by angiography (677patients) orfol- 
low-up and outcome classification (166 patients). 
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The method of outcome classification has been de- 
scribed.2 
Chest radiographs were obtained within 24 hours 
of angiography in all patients. The partial pressure of 
oxygen in arterial blood (PaOj), with the patient 
breathing room air, was measured within 24 hours 
before the diagnostic pulmonary angiogram in 280 
patients with and 624 patients without PE. Detailed 
methods have been reported.2 
A chi-square with Yates’ correction was used to 
compare the prevalence and distribution of clinical 
features. Because of the large number of comparisons 
made in this analysis, p values tend to exaggerate the 
statistical significance of observed differences. Com- 
parisons of continuous variables were made with a 
Student’s t test. Data were analyzed at the Henry Ford 
Heart and Vascular Institute from a tape provided by 
the PIOPED Data and Coordinating Center. The pa- 
tients with acute PE were 58 f 17 years of age (mean 
f standard deviation); 204 were men (53%). Patients 
in whom PE was excluded were 55 f 18 years of age; 
355 (42%) were men. Among the 383 patients with 
acute PE the most frequent symptoms were dyspnea 
in 299 (78%),pleuriticpain in 225 (59%) and cough in 
166 (43%). The most frequent signs of PE were tachy- 
pnea (respiratory rate 120 beatslmin) in 278 (73%), 
rales in 210 (55%) and tachycardia (heart rate >lOO 
beatslmin) in 115 (30%). The frequency of symptoms 
and signs in 843 patients with no PE was not signifi- 
cantly different. The most frequent radiographic ab- 
normality was atelectasis or a pulmonary parenchy- 
ma1 abnormality, either or both of which were ob- 
served in 263 patients (69%) with and 483 (58%) 
without PE (p <O.OOl). A pleural effusion was pre- 
sent in 180 (47%) with and in 327 (39%) without PE 
(p X0.01 ). A pleural-based opacity was present in 132 
(34%) with and 223 (26%) without PE (p <O.Ol). An 
elevated diaphragm was present in 106 (28%) with 
and in 175 (21%) without PE (p X0.01). The Pa02 
while breathing room air was <80 mm Hg in 226 
of 280 (81%) with and 458 of 624 (73%) without PE 
(p <0.05). 
Combinations of signs, symptoms, radiographic fea- 
tures and Pa02 most frequently present in patients with 
PE are listed in Table I. These combinations of clinical 
characteristics occurred with nearly the same frequency 
(within 1%) among patients in whom PE was excluded. 
Combinations of signs and symptoms associated with 
PE in patients with no prior cardiopulmonary disease 
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TABLE I Combinations of Clinical Findings in Patients with 
most all patients with acute PE. Dyspnea or tachypnea or 
pleuritic pain or radiographic evidence of atelectasis or a 
parenchymal abnormality occurred in 99% of patients. 
All natients with PE had dvsnnea or tachvnnea or uleu- 
Dyspnea or tachypnea* 
Dyspnea, tachypnea or pleuritic pain 
Dyspnea, tachypnea, pleuritic pain or DVT 






Dyspnea, tachypnea, pleuritic pain, DVT or x-ray 381/383 (99) 
atelectasislparenchymal 
Dyspnea, tachypnea, pleuritic pain, DVT, x-ray 280/280 (100) 
atelectasis/parenchymal or Pa02 < 80 mm Hg 
*Tachypnea = respiratory rate 220 beatslmin. 




d I II 
only a small percentage did not have a number of impor- 
ritic pain or deep venous thrombosis or atelectasis/paren- 
chymal abnormality or a Pa02 <80 mm Hg. These data 
indicate that among; patients in whom PE was identified, 
tant manifestations. These manifestations are not specif- 
ic for PE, and their presence does not necessarily warrant 
initiation of an investigation for PE. However, the recog- 
nition of these manifestations assists in identifying pa- 
tients in whom ventilation/perfusion scans or angiogra- 
phy, or both, may be necessary. 
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Lymphoproliferative Disorder Early After Cardiac Transplantation 
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and William B. Bugni, MD 
I n cardiac transplantation, extremely potent immu- nosuppressive agents are used, which leave the host vulnerable to a variety of infections and malignan- 
cies. Among the malignancies, lymphoproliferative dis- 
orders are the most common.’ Most cases of posttrans- 
plant lymphoproliferative disorders have been described 
in patients who have undergone several months of immu- 
nosuppression. 2p3 This report describes our experience 
with patients who developed lymphoproliferative disor- 
der within 3 months of heart transplantation. 
Our patient population includes all patients who 
underwent cardiac transplantation at the University 
of South Florida/Tampa General Hospital and at St. 
Joseph’s Hospital in Tampa, Florida. As of December 
1989, 79 patients had undergone heart transplanta- 
tion at University of South Florida/Tampa General 
Hospital and 13 at St. Joseph’s Hospital. All patients 
received immunosuppressive therapy with cyclospor- 
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ine, azathioprine and prednisone in doses adjusted to 
the overall clinical condition. In addition, during 
1989, “induction” or prophylactic immunosuppres- 
sive therapy with OKT3 was initiated within 48 hours 
of cardiac transplantation. OKT3 was administered 
by an intravenous infusion of 5 mg/day for 14 consec- 
u tive days. 
We defined lymphoproliferative disorder as a his- 
tologically documented disorder characterized by un- 
controlled monoclonal or polyclonal proliferation of 
B lymphocytes within, or separate from, lymph nodes. 
Clinical data were obtained from individual medical 
records. 
Table I outlines the salient features in our patients 
with lymphoproliferative disorder. All patients re- 
ceived OKT3, 3 as part of a prophylactic “induction” 
protocol and 2 as rescue therapy for acute early cardi- 
ac rejection unresponsive to high-dose intravenous 
corticosteroid therapy. The initial clinical presenta- 
tion included fever, lymphadenopathy and abnormal 
liver function tests. In 3 patients the clinical course 
was one of rapid irreversible multisystem failure and 
at autopsy all 3patients with active lymphoprolifera- 
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